In this CME Outfitters BriefCase, expert faculty will utilize real-world case studies to explore gaps in clinician and patient adherence to the MREMS, including discussions and/or demonstrations of counseling, pregnancy testing, acceptable contraception methods, and monitoring of confirmed pregnancies via the Mycophenolate Pregnancy Registry to support ongoing pharmacovigilance.
In this CME Outfitters BriefCase, expert faculty will use case examples to highlight the current clinical guidelines for biomarker testing and advise learners on addressing ethnic, geographic, and socioeconomic barriers to optimal utilization of biomarker testing in lung cancer.
In this CME Outfitters BriefCase, expert faculty will discuss the impact of implicit bias and structural inequities on referral patterns, access to bariatric surgery, and postoperative outcomes across diverse patient populations, as well as evidence-based approaches to reduce disparities in bariatric surgery.
In the second activity of this CME Outfitters BriefCase series, expert faculty will utilize a patient case format to illustrate approaches for diagnosing AD, implementing treatment that includes MDT care, and practicing SDM to achieve optimal patient outcomes.
In the first activity of this CME Outfitters BriefCase series, expert faculty will utilize a patient case format to illustrate utilization of current and emerging screening and diagnostic tools in diverse populations for early detection of AD, as well as integration of culturally sensitive patient and caregiver education strategies to improve SDM on brain health and AD management with patients.
In this second of two, interactive CMEO BriefCase demonstrations, an expert faculty will react to the actions taken by a clinician when her patient becomes pregnant while taking mycophenolate three years post-kidney transplantation. The program will emphasize pros and cons about the clinician-patient interactions highlighted in the vignettes, while offering practical information on the steps involved for both patients and clinicians to participate in the Mycophenolate Pregnancy Registry.
